AA
TPPH

Ancora Advisors’s TAPESTRY PHARMACEUTICALS INC NEW TPPH Stock Holding History

Ancora Advisors’s Portfolio TPPH Stock Details TPPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,248,000
Closed – – 1880
2023
Q2 		$0 Hold
1,248,000
– – ﹤0.01% 2021
2023
Q1 		$0 Hold
1,248,000
– – ﹤0.01% 2268
2022
Q4 		$0 Hold
1,248,000
– – ﹤0.01% 2432
2022
Q3 		$0 Hold
1,248,000
– – ﹤0.01% 2503
2022
Q2 		$0 Hold
1,248,000
– – ﹤0.01% 2693
2022
Q1 		$0 Hold
1,248,000
– – ﹤0.01% 2849
2021
Q4 		$0 Hold
1,248,000
– – ﹤0.01% 2578
2021
Q3 		$0 Hold
1,248,000
– – ﹤0.01% 2381
2021
Q2 		$0 Hold
1,248,000
– – ﹤0.01% 2197
2021
Q1 		$0 Hold
1,248,000
– – ﹤0.01% 1887
2020
Q4 		$0 Hold
1,248,000
– – ﹤0.01% 1599
2020
Q3 		$0 Hold
1,248,000
– – ﹤0.01% 1508
2020
Q2 		$0 Hold
1,248,000
– – ﹤0.01% 1535
2020
Q1 		$0 Hold
1,248,000
– – ﹤0.01% 1570
2019
Q4 		$0 Buy
+1,248,000
New – ﹤0.01% 1402

Ancora Advisors's TPPH Position: Q3 2023 in Review

Ancora Advisors sold out of TAPESTRY PHARMACEUTICALS INC NEW (TPPH) in Q3 2023, closing a stake of 1,248,000 shares.

Ancora Advisors first reported a position in TPPH in Q4 2019 and held it in 15 quarters. The position peaked at $0 in Q2 2023. 0 funds tracked by Wall St. Rank hold TPPH as of Q3 2023.

  • Ancora Advisors reported no remaining TAPESTRY PHARMACEUTICALS INC NEW position as of Q3 2023 after selling out during the quarter.
  • Ancora Advisors sold 1,248,000 TAPESTRY PHARMACEUTICALS INC NEW shares in Q3 2023.
  • Ancora Advisors first reported a position in TAPESTRY PHARMACEUTICALS INC NEW in Q4 2019 and held it in 15 quarters.
  • Ancora Advisors's TAPESTRY PHARMACEUTICALS INC NEW position peaked at $0 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held TAPESTRY PHARMACEUTICALS INC NEW as of Q3 2023.

Based on Ancora Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.